These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 10894461)
41. [Management of bronchiectasis antibiotic therapy excepted. Non-antibiotic therapy of children and adults]. Kalendarov D; Hubert D Rev Pneumol Clin; 2001 Sep; 57(4 Pt 2):S31-5; discussion S35-6. PubMed ID: 11887437 [No Abstract] [Full Text] [Related]
42. [Clinico-experimental examination of different propellant gas combinations in a corticoid dosed aerosol]. Uhl O Arzneimittelforschung; 1969 Oct; 19(10):1748-51. PubMed ID: 5395378 [No Abstract] [Full Text] [Related]
43. [Insanovin aerosol therapy in the treatment of bronchial asthma]. Insanov AB; Mustafaeva LI Probl Tuberk Bolezn Legk; 2004; (7):29-31. PubMed ID: 15379038 [TBL] [Abstract][Full Text] [Related]
45. Mucolytics, expectorants, and mucokinetic medications. Rubin BK Respir Care; 2007 Jul; 52(7):859-65. PubMed ID: 17594730 [TBL] [Abstract][Full Text] [Related]
46. Local treatment of upper respiratory tract conditions. Role of Locabiotal Aerosol (fusafungine). Proceedings of an international meeting. Athens, April 28-May 1, 1988. Rhinol Suppl; 1988; 5():1-79. PubMed ID: 3244979 [No Abstract] [Full Text] [Related]
47. Methodological optimization of polyethylenimine (PEI)-based gene delivery to the lungs of mice via aerosol application. Rudolph C; Ortiz A; Schillinger U; Jauernig J; Plank C; Rosenecker J J Gene Med; 2005 Jan; 7(1):59-66. PubMed ID: 15538727 [TBL] [Abstract][Full Text] [Related]
48. Potential of helper-dependent adenoviral vectors in modulating airway innate immunity. Kushwah R; Cao H; Hu J Cell Mol Immunol; 2007 Apr; 4(2):81-9. PubMed ID: 17484801 [TBL] [Abstract][Full Text] [Related]
49. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. Vigna E; Naldini L J Gene Med; 2000; 2(5):308-16. PubMed ID: 11045424 [TBL] [Abstract][Full Text] [Related]
50. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action]. Kupczyk M; Kuna P Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600 [TBL] [Abstract][Full Text] [Related]
51. New horizons in respiratory care: the pharmacology of inhaled aerosol drug therapy. Fink JB; Rau JL Respir Care; 2000 Jul; 45(7):824-5. PubMed ID: 10926378 [No Abstract] [Full Text] [Related]
52. Aerosol therapy: regimen and device compliance in daily practice. Everard ML Paediatr Respir Rev; 2006; 7 Suppl 1():S80-2. PubMed ID: 16798605 [No Abstract] [Full Text] [Related]
53. Applications of adenoviral vector-mediated gene transfer in cardiovascular research. Xu F; Serra D; Amalfitano A Methods Mol Med; 2006; 129():209-39. PubMed ID: 17085814 [TBL] [Abstract][Full Text] [Related]
57. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors. Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203 [TBL] [Abstract][Full Text] [Related]
58. Gene transfer into human epidermis as an experimental model for somatic gene therapy. Jensen TG Dan Med Bull; 2004 May; 51(2):155-66. PubMed ID: 16009054 [No Abstract] [Full Text] [Related]